Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Chemours CoWBO:CHEM -3.11%43 ROC (Joel Greenblatt) % is 4.71% as of Mar. 2026, which is 52% below its 10-year median of 9.72. GuruFocus rates WBO:CHEM with a GF Score™ of 43/100 and a GF Value™ of €17.38 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,605 Chemicals companies, The Chemours Co ranks worse than 78.13% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. The Chemours Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.71%.
The historical rank and industry rank for The Chemours Co's ROC (Joel Greenblatt) % or its related term are showing as below:
WBO:CHEM'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -3.04 Med: 9.72 Max: 39.38
Current: -0.66
During the past 13 years, The Chemours Co's highest ROC (Joel Greenblatt) % was 39.38%. The lowest was -3.04%. And the median was 9.72%.
WBO:CHEM's ROC (Joel Greenblatt) % is ranked worse than 78.13% of 1605
companies
in the Chemicals industry
Industry Median: 9.55
vs WBO:CHEM: -0.66
The Chemours Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
The Chemours Co (WBO:CHEM) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The Chemours Co ROC (Joel Greenblatt) % Related Terms
The Chemours Co ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for The Chemours Co's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:CHEM vs KWR, NGVT, MTX: ROC (Joel Greenblatt) % Comparison
For the Specialty Chemicals subindustry, The Chemours Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Chemours Co ROC (Joel Greenblatt) % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, The Chemours Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where The Chemours Co's ROC (Joel Greenblatt) % falls into.
The Chemours Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 4.71% mean?
The Chemours Co (WBO:CHEM) has a ROC (Joel Greenblatt) % of 4.71% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on The Chemours Co and its competitors. This is 52% below median its historical median of 9.72. According to the industry distribution chart, The Chemours Co ranks #1254 out of 1605 companies in the Chemicals industry, placing it in the top 78.1%.
Is The Chemours Co's ROC (Joel Greenblatt) % too high?
The Chemours Co's current ROC (Joel Greenblatt) % of 4.71% is 52% below median its 10-year median of 9.72. The Chemicals industry median ROC (Joel Greenblatt) % is 9.55. The Chemours Co's value of 4.71% is 50.7% below this industry median. Based on the distribution chart, The Chemours Co ranks #1254 out of 1605 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, The Chemours Co has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Chemours Co's ROC (Joel Greenblatt) % compare to KWR and NGVT?
According to the Chemicals industry distribution chart, The Chemours Co ranks #1254 out of 1605 companies for ROC (Joel Greenblatt) %. This places The Chemours Co in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 9.55. The Chemours Co's value of 4.71% is 50.7% below this benchmark. While the company's 10-year median is 9.72 vs. the industry median of 9.55, The Chemours Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Chemicals company?
The median ROC (Joel Greenblatt) % among Chemicals companies is 9.55, based on 1,605 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Chemours Co's current ROC (Joel Greenblatt) % of 4.71% is 50.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on The Chemours Co and its competitors. For the Chemicals industry, the median ROC (Joel Greenblatt) % is 9.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Chemours Co's current ROC (Joel Greenblatt) % is 4.71%, which is 52% below median its own 10-year median of 9.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Chemours Co stock overvalued right now?
Based on GuruFocus' analysis, The Chemours Co (WBO:CHEM) is currently considered Modestly Undervalued. The stock's GF Value™ is €17.38, compared to a current price of €14.81 — trading 14.8% below its estimated fair value. The current ROC (Joel Greenblatt) % is 4.71%, which is 52% below median its 10-year median of 9.72 and 50.7% below the Chemicals industry median of 9.55. The Chemours Co's overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For The Chemours Co (WBO:CHEM), the current ROC (Joel Greenblatt) % is 4.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Chemours Co (WBO:CHEM) Overvalued in 2026?
Based on GuruFocus' analysis, The Chemours Co stock appears to be undervalued.
The current stock price of €14.81 is trading 14.8% below its estimated GF Value™ of €17.38.
GuruFocus considers The Chemours Co to be Modestly Undervalued.
Key valuation signals for WBO:CHEM:
ROC (Joel Greenblatt) %: 4.71% (52% below median its 10-year median of 9.72)
GF Value™: €17.38 vs. price of €14.81 (14.8% below fair value)
Industry Position: 50.7% below the Chemicals median (#1254 of 1605)
No single metric tells the full story. See the WBO:CHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
43GF Score
Get the complete analysis for WBO:CHEM
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:CHEM has been successfully added to your 
